Marshall Wace North America’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Marshall Wace North America’s Portfolio NXGN Stock Details NXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-24,497	Closed	-$312K	–	1660
2020 Q3	$312K	Sell	24,497 -26,828	-52%	-$343K	﹤0.01%	1064
2020 Q2	$564K	Sell	51,325 -16,964	-25%	-$176K	﹤0.01%	902
2020 Q1	$713K	Buy	+68,289	New	+$881K	0.01%	685
2019 Q2	–	Sell	-6,241	Closed	-$105K	–	1725
2019 Q1	$105K	Hold	6,241	–	–	﹤0.01%	1108
2018 Q4	$95K	Buy	+6,241	New	+$107K	﹤0.01%	1091
2017 Q2	–	Sell	-30,084	Closed	-$451K	–	1497
2017 Q1	$451K	Buy	+30,084	New	+$443K	﹤0.01%	827

Other funds holding NXGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace North America's NXGN Position: Q4 2020 in Review

Marshall Wace North America sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2020, closing a stake of 24,497 shares — an estimated $312K sold.

Marshall Wace North America first reported a position in NXGN in Q1 2017 and held it in 6 quarters. The position peaked at $713K in Q1 2020. 152 funds tracked by Wall St. Rank hold NXGN as of Q4 2020.

Marshall Wace North America reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Marshall Wace North America sold 24,497 NextGen Healthcare, Inc. Common Stock shares in Q4 2020, an estimated $312K.
Marshall Wace North America first reported a position in NextGen Healthcare, Inc. Common Stock in Q1 2017 and held it in 6 quarters.
Marshall Wace North America's NextGen Healthcare, Inc. Common Stock position peaked at $713K in Q1 2020.
152 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.